Related Experiment Video
Updated: Jan 16, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Hypertensive Proliferative Choriorretinopathy
Guilherme Portas-Almeida1, Catarina Oliveira Rodrigues, Rita Guerra Pinto
1Ophthalmology Department, São José Local Health Unit, Lisbon, Portugal.
Severe hypertension can cause vision loss through hypertensive chorioretinopathy and neovascularization. Panretinal photocoagulation (PRP) was ineffective, highlighting the need for strict blood pressure control.
Area of Science:
- Ophthalmology
- Vascular Medicine
Background:
- Hypertensive chorioretinopathy is a serious complication of uncontrolled hypertension.
- Anterior segment neovascularization can arise secondary to retinal ischemia.
Purpose of the Study:
- To present a case of hypertensive chorioretinopathy with anterior segment neovascularization.
- To evaluate treatment response, particularly to panretinal photocoagulation (PRP).
Main Methods:
- Case report detailing a patient with severe, uncontrolled hypertension.
- Diagnostic imaging included fundoscopy, fluorescein angiography, and indocyanine green angiography.
- Treatment involved intravitreal anti-VEGF injections and PRP.
Main Results:
- The patient presented with progressive vision loss and anterior segment neovascularization.
- Angiography confirmed severe retinal ischemia and delayed choroidal perfusion.
- PRP and anti-VEGF initially controlled neovascularization, but it recurred, necessitating further anti-VEGF therapy.
Conclusions:
- Choroidal ischemia in hypertensive chorioretinopathy may be refractory to PRP.
- Effective management requires stringent systemic hypertension control.
- Regular monitoring is crucial to prevent vision-threatening complications.
More Related Videos
12:28Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
Published on: March 12, 2022
08:10An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
Published on: January 25, 2019
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...